Ignite Creation Date:
2025-12-24 @ 7:12 PM
Ignite Modification Date:
2026-07-19 @ 2:17 AM
Study NCT ID:
NCT02803203
Status:
COMPLETED
Last Update Posted:
2023-09-22
First Post:
2016-06-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Osimertinib and Bevacizumab as Treatment for EGFR-mutant Lung Cancers
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization: